Skip to main content

ABVX · Abivax S.A. · Analyst Estimates

Track ABVX — free
$92.88 -2.22 (-2.33%) At close · Oct 2
Market Cap
$8.14B
Shares
87.25M
Volume · Oct 2 644.38K Avg daily vol (3M) 1.09M

Analyst Estimates

Compare analyst forecasts for Abivax S.A. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-04 06:50 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.668
-4.2405
-3.891
—
-3.58533
-3.58533
-3.58114
-3.65883
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
6
6
0
0
Revenue
EUR
Publication date not stated
0
3678020
5527000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.909
-3.88171
-2.575
—
-3.14633
-3.14633
-3.34271
-3.27033
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
4
4
2
2
Revenue
EUR
Publication date not stated
0
71871740
374700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
15
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.113
-0.9025
-0.606
—
-0.67267
-0.67267
-0.763
-0.71167
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
3
0
0
1
Revenue
EUR
Publication date not stated
0
691610
1401000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.158
-0.8975
-0.652
—
-0.77175
-0.77175
-0.77175
-0.77325
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
4
4
0
0
Revenue
EUR
Publication date not stated
0
701190
1581000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1956827 CUSIP 00370M103 13F (30d) 8 filings 8 filers Visit website Investor relations